Methotrexate 25 mg / mL Injection 40 mL
Comprehensive product details for sourcing and verification.
| NDC 11 | 61703-0408-41 |
|---|---|
| Product NDC | 61703-0408 |
| Generic Drug Name | Methotrexate |
| Brand Name | Methotrexate |
| Manufacturer | Hospira, Inc. |
| Strength | 25 mg / mL |
| Dosage Form | Injection |
| Drug Type | Intramuscular; Intrathecal; Intravenous; Subcutaneous |
| Package Quantity | 1 Vial, Single-Dose |
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-408-41) / 40 mL in 1 VIAL, SINGLE-DOSE |
| Active Ingredients | Methotrexate Sodium |
| Marketing Category | NDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
Methotrexate 25 mg / mL Injection is tracked under NDC 61703-0408-41 and rolls up into product family 61703-0408. Use this page to confirm the exact presentation before moving into related family or manufacturer pathways.
- Package configuration: 1 Vial, Single-Dose.
- Manufacturer: Hospira, Inc..
- Dosage form: Injection.
- Family size: 2 active presentations.
Click a tag to refine the catalog view around this exact presentation.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Alternate presentations in this family
These nearby exact-item pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.
Drug Shortage Information
This NDC has appeared in documented shortage listings three times since 2012, a recurring pattern that suggests elevated future supply risk.
Drug Shortage Index family
View Methotrexate in the Drug Shortage IndexCompare related exact NDC products and family-level shortage context for Methotrexate.Source: Public FDA drug shortage records accessed through FDA-owned openFDA drug shortages queries.
This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
Methotrexate 25 mg / mL Injection 40 mL, NDC 61703-0408-41, is a Hospira, Inc. 25 mg / mL injection presentation packaged as 1 Vial, Single-Dose. Historical public shortage information is available for this exact presentation.
NDC search formats
- Canonical NDC 11: 61703-0408-41.
- Digits-only NDC 11: 61703040841.
- Possible 10-digit display format: 61703-408-41 (6170340841).
Helpful product links
- Search by brand name: Methotrexate.
- Exact NDC 11: 61703-0408-41.
- Product family NDC: 61703-0408.
- Compare related presentations: Methotrexate 25 mg / mL Injection 40 mL.
Related shortage research
If your team is researching the broader shortage picture, the family page groups related exact NDC items, brand variations, and family-level shortage context in one place.